178 related articles for article (PubMed ID: 37663814)
1. HM-chromanone alleviates hyperglycemia and inflammation in mice with endotoxin-induced insulin resistance.
Lim HJ; Park JE; Han JS
Toxicol Res (Camb); 2023 Aug; 12(4):665-674. PubMed ID: 37663814
[TBL] [Abstract][Full Text] [Related]
2. HM-chromanone attenuates TNF-α-mediated inflammation and insulin resistance by controlling JNK activation and NF-κB pathway in 3T3-L1 adipocytes.
Park JE; Kang E; Han JS
Eur J Pharmacol; 2022 Apr; 921():174884. PubMed ID: 35288193
[TBL] [Abstract][Full Text] [Related]
3. HM-Chromanone, a Major Homoisoflavonoid in
Park JE; Han JS
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145191
[TBL] [Abstract][Full Text] [Related]
4. HM-chromanone isolated from
Park JE; Han JS
Toxicol Res (Camb); 2023 Aug; 12(4):648-657. PubMed ID: 37663815
[TBL] [Abstract][Full Text] [Related]
5. A bioactive component of
Park JE; Han JS
Toxicol Res (Camb); 2022 Oct; 11(5):774-783. PubMed ID: 36337245
[TBL] [Abstract][Full Text] [Related]
6. HM-Chromanone Isolated from
Park JE; Seo Y; Han JS
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30769910
[TBL] [Abstract][Full Text] [Related]
7. HM-chromanone from Portulaca oleracea L. inhibits protein tyrosine phosphatase 1B and mitigates glucose production in insulin-resistant HepG2 cells.
Lim HJ; Park JE; Han JS
Fitoterapia; 2023 Jun; 167():105512. PubMed ID: 37080256
[TBL] [Abstract][Full Text] [Related]
8. A new chromanone isolated from Portulaca oleracea L. increases glucose uptake by stimulating GLUT4 translocation to the plasma membrane in 3T3-L1 adipocytes.
Park JE; Park JY; Seo Y; Han JS
Int J Biol Macromol; 2019 Feb; 123():26-34. PubMed ID: 30389528
[TBL] [Abstract][Full Text] [Related]
9. HM-chromanone suppresses hepatic glucose production via activation of AMP-activated protein kinase in HepG2 cell.
Park JE; Han JS
Eur J Pharmacol; 2022 Aug; 928():175108. PubMed ID: 35718128
[TBL] [Abstract][Full Text] [Related]
10. HM-chromanone, a component of Portulaca oleracea L., stimulates glucose uptake and glycogen synthesis in skeletal muscle cell.
Park JE; Seo Y; Han JS
Phytomedicine; 2021 Mar; 83():153473. PubMed ID: 33513558
[TBL] [Abstract][Full Text] [Related]
11. HM-chromanone reverses the blockade of insulin signaling induced by high glucose levels in human HepG2 cells.
Park JE; Han JS
Eur J Pharmacol; 2022 Dec; 937():175358. PubMed ID: 36332682
[TBL] [Abstract][Full Text] [Related]
12. (
Kang E; Park JE; Seo Y; Han JS
Immunopharmacol Immunotoxicol; 2021 Oct; 43(5):611-621. PubMed ID: 34388059
[TBL] [Abstract][Full Text] [Related]
13. HM-Chromanone Ameliorates Hyperglycemia and Dyslipidemia in Type 2 Diabetic Mice.
Park JE; Son J; Seo Y; Han JS
Nutrients; 2022 May; 14(9):. PubMed ID: 35565920
[TBL] [Abstract][Full Text] [Related]
14. HM-Chromanone Alleviates Hyperglycemia by Protecting Pancreatic Islet Cells in Streptozotocin-Induced Diabetic Mice.
Park JE; Han JS
J Med Food; 2023 Jun; 26(6):357-367. PubMed ID: 37083465
[TBL] [Abstract][Full Text] [Related]
15. 5,7-Dimethoxy-3-(2'-hydroxybenzyl)-4-chromanone inhibits α-glucosidase in vitro and alleviates postprandial hyperglycemia in diabetic mice.
Park J; Park JE; Seo YW; Han JS
Eur J Pharmacol; 2019 Nov; 863():172683. PubMed ID: 31550448
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of glucose intolerance by the synthetic androstene HE3286: link to inflammatory pathways.
Wang T; Villegas S; Huang Y; White SK; Ahlem C; Lu M; Olefsky JM; Reading C; Frincke JM; Alleva D; Flores-Riveros J
J Pharmacol Exp Ther; 2010 Apr; 333(1):70-80. PubMed ID: 20068030
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo.
Yang P; Zhao Y; Zhao L; Yuan J; Chen Y; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
Sci Rep; 2015 Oct; 5():14959. PubMed ID: 26449763
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
19. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Rim HK; Cho W; Sung SH; Lee KT
J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
[TBL] [Abstract][Full Text] [Related]
20. The mechanisms of carnosic acid attenuates tumor necrosis factor-α-mediated inflammation and insulin resistance in 3T3-L1 adipocytes.
Tsai CW; Liu KL; Lin YR; Kuo WC
Mol Nutr Food Res; 2014 Apr; 58(4):654-64. PubMed ID: 24668853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
